Cognitive therapy software for improving cognitive function for patients with mild cognitive impairment (SB‐DEX): A multicenter, prospective, comparative, randomized, independent rater‐blind, superiority, pivotal clinical trial to compare the safety and efficacy of the Cognitive therapy software ‘SUPERBRAIN DEX’ for improving cognitive function with a control group for patients with mild cognitive impairment (ClinicalTrials.gov ID NCT06264557)

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Alzheimer's & Dementia vol. 21 (Dec 1, 2025)
Yazar: Choi, Hojin
Diğer Yazarlar: Minn, Yangki, Kang, Sungmin, Han, Seunghyun
Baskı/Yayın Bilgisi:
John Wiley & Sons, Inc.
Konular:
Online Erişim:Citation/Abstract
Full Text - PDF
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!